FDA Adverse Event Malfunction Summary report: N

NEULASTA OBI

MDR report key: 12786274 · Received November 10, 2021

Report

Report Number
12786274
Event Type
Malfunction
Date Received
November 10, 2021
Date of Event
July 20, 2021
Report Date
November 9, 2021
Manufacturer
AMGEN INC.
Product Code
KZH
Product Problem
Yes
Report Source
User Facility report
Reporter Location
ME
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Description of Event or Problem · 0

NARRATIVE FROM STAFF: PATIENT HAD QUESTIONABLE INJECTION OF NEULASTA OBI ON CYCLE #1 OF CHEMO. PATIENT CALLED IN AND REPORTED FAILURE OF DEVICE. UNCLEAR IF IT WAS ADDRESSED BY COVERING PROVIDER. PATIENT WAS SUBSEQUENTLY ADMITTED FOR SEPSIS AND HAD SUBSEQUENT CYCLES OF CHEMOTHERAPY DOSE REDUCED. OUR TEAM WAS INFORMED OF THIS EVENT LAST WEEK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1687851 NEULASTA OBI INTRODUCER, SYRINGE NEEDLE KZH AMGEN INC. 1131930D

Patients

Seq Age Sex Outcome Treatment
1 27740 DA Female